This inventor holds 2 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 1998-1999.
Company Filing History:
Years Active: 1998-1999
Title: Michael Boretzky: Innovator in Antitumor Peptides
Introduction
Michael Boretzky is a notable inventor based in Offenbach, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of antitumor agents. With a total of 2 patents to his name, Boretzky's work is recognized for its potential impact on cancer treatment.
Latest Patents
Boretzky's latest patents include innovative peptides designed to combat tumors. The first patent, titled "Tetrapeptides as Antitumor Agents," presents anti-tumor peptides of Formula I. The second patent, "Pentapeptides as Antitumor Agents," also provides anti-tumor peptides of Formula I. These inventions highlight his commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Michael Boretzky is currently employed at BASF Aktiengesellschaft, a leading global chemical company. His role at BASF allows him to collaborate with other experts in the field and contribute to groundbreaking research. His work has positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Boretzky has worked alongside talented colleagues, including Teresa Barlozzari and Andreas Haupt. Their combined expertise fosters an environment of innovation and creativity, driving forward the research and development of effective antitumor solutions.
Conclusion
Michael Boretzky's contributions to the field of antitumor peptides demonstrate his dedication to improving cancer treatment. His innovative patents and collaborative efforts with colleagues underscore the importance of teamwork in scientific advancement.